Doctors at Eastern Virginia Medical School’s Strelitz Diabetes Center have been stalking the culprit responsible for Type 1 diabetes. Now, they are one step closer.

Members of a research team at the centre, led by Jerry Nadler, MD, professor and chair of internal medicine and director of the centre, have been studying the role of the enzyme 12-Lipoxygenase (12-LO) in the development of Type 1 diabetes. They hope that targeting this enzyme will hold the key to a cure.

Read more

Related posts:

1. GPs must reassess diabetes patients
2. NHS Diabetes Publishes Self-Monitoring Of Blood Glucose Report – Diabetes UK
3. Evaluation of DOK5 as a susceptibility gene for type 2 diabetes and obesity in North Indian population
4. La Asociación Americana de la Diabetes alienta a las organizaciones comunitarias a unirse al movimiento para ponerle Alto a la Diabetes
5. Development of an Internet Coping Skills Training Program for Teenagers With Type 1 Diabetes.